Latest News for: cel

Edit

CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine� to Market for ...

Business Wire 13 Jul 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to launch FDA Registration-Enabling Phase 3 Confirmatory Study to bring Multikine to Market for newly diagnosed head and neck cancer ... .
Edit

CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer (CEL-SCI Corporation)

Public Technologies 13 Jul 2026
CEL-SCI Corporation (NYSE American ... Orient EuroPharma, CEL-SCI's strategic partner in Taiwan, will oversee and fund patient enrollment within its territory ... About CEL-SCI Corporation ... CEL-SCI Corporation.
Edit

How the ‘Clevatess’ Crew Made a Dark Fantasy Anime Celebrating Cel Animation

Gizmodo 11 Jul 2026
Kadokawa and Lay-duce talked to io9 about how IRL child rearing and a reverence for Hollywood classics willed its comedic dark fantasy series into being ....
Edit

PRESERVING THE GENRE-DEFINING VISIONS: SCI-FI ANIME PRODUCTION CELS UP FOR AUCTION

Norfolk Daily News 02 Jul 2026
Akira, Ghost In The Shell, Cowboy Bebop, Neon Genesis Evangelion, Macross and more Sci-Fi Anime Classics From Akira to ... .
Edit

Annual Report (Form ARS) (CEL-SCI Corporation)

Public Technologies 02 Jul 2026
CEL-SCI Corporation published this content on July 02, 2026, and is solely ...
Edit

Proxy Statement (Form DEF 14A) (CEL-SCI Corporation)

Public Technologies 02 Jul 2026
CEL-SCI CORPORATION ... Notice is hereby given that the annual meeting of the shareholders of CEL-SCI Corporation ("CEL-SCI") will be held at the offices of CEL-SCI at 8229 Boone Blvd., Vienna, Virginia 22182 on August 14, 2026 at 10.00 a.m.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (CEL-SCI Corporation)

Public Technologies 01 Jul 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ... 0.5 ... CEL SCI CORP [CVM] 5 ... CEL-SCI Corporation published this content on July 01, 2026, and is solely responsible for the information contained herein.
Edit

CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.–Saudi Cooperation ...

The Joplin Globe 24 Jun 2026
VIENNA, Va.--(BUSINESS WIRE)--Jun 24, 2026-- ... .
Edit

CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.-Saudi Cooperation in Cancer Care (CEL-SCI Corporation)

Public Technologies 24 Jun 2026
CEL-SCI Corporation (NYSE American ... CEL-SCI and Saudi Amarox sign landmark agreement at BIO 2026 to advance U.S.-Saudi cooperation in cancer care ... About CEL-SCI Corporation ... CEL-SCI Corporation.
Edit

CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

PR Newswire 22 Jun 2026
Satri-cel is the world's first approved CAR T-cell therapy product for the treatment of solid tumors ... Satri-cel is an autologous CAR-T cell product targeting Claudin18.2 ... of satri-cel ... About Satri-cel.
Edit

CEL-SCI Announces Closing of Offering

Norfolk Daily News 17 Jun 2026
CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American. CVM), a clinical stage cancer immunotherapy company, ... .
Edit

CEL-SCI CORPORATION ANNOUNCES PRICING OF OFFERING (Form 8-K) (CEL-SCI Corporation)

Public Technologies 16 Jun 2026
CEL-SCI CORPORATION ANNOUNCES PRICING OF OFFERING. Vienna, VA, June 14, 2026 - CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE American ... CEL-SCI Corporation published this ...
Edit

CEL-SCI Advances Multikine� Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and ...

Business Wire 16 Jun 2026
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI advances Multikine immunotherapy for Head and Neck Cancer through dual U.S. registration study and Saudi market entry strategy ... .
Edit

CEL-SCI Corporation Announces Pricing of Offering

Killeen Daily Herald 15 Jun 2026
CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American. CVM), a clinical stage cancer immunotherapy company, ....
Edit

CEL-SCI Corporation Announces Pricing of Offering (CEL-SCI Corporation)

Public Technologies 15 Jun 2026
CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE American ... About CEL-SCI Corporation ... * Multikine (Leukocyte Interleukin, Injection) is the trademark that CEL-SCI has registered for this investigational therapy.

Article Search

tools
×
×
×
×